COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,184 Articles (22,713 medRxiv, 8,471 bioRxiv)

Most recent first Previous |  Page 2641: Articles 26401-26410  | Next

Understanding the impact of the COVID-19 pandemic on well-being and virtual care for people living with dementia and care partners living in the community
Roach, P., Zwiers, A., Cox, E., Fischer, K., Charlton, A., Josephson, C. B., Patten, S. B., Seitz, D., Ismail, Z., Smith, E. E., Prompt Collaborators
10.1101/2020.06.04.20122192 — Posted: 2020-06-05
Insights on cross-species transmission of SARS-CoV-2 from structural modeling
Rodrigues, J. P., Barrera-Vilarmau, S., Teixeira, J. M., Seckel, E., Kastritis, P. L., Levitt, M.
10.1101/2020.06.05.136861 — Posted: 2020-06-05
Profiles of Social Distance Compliance: Psychological and Situational Predictors of Risky Behavior during COVID-19
Haupt, M. R., Weiss, S. M., Chiu, M., Cuomo, R., Chein, J., McKay, T.
10.1101/2020.06.04.20122754 — Posted: 2020-06-05
Whole genome identification of potential G-quadruplexes and analysis of the G-quadruplex binding domain for SARS-CoV-2
Zhang, R., Xiao, K., Gu, Y., Liu, H., Sun, X.
10.1101/2020.06.05.135749 — Posted: 2020-06-05
HIGH LIVER FAT ASSOCIATES WITH HIGHER RISK OF DEVELOPING SYMPTOMATIC COVID-19 INFECTION - INITIAL UK BIOBANK OBSERVATIONS
Roca-Fernandez, A., Dennis, A., Nicolls, R., McGonigle, J., Kelly, M., Banerjee, R.
10.1101/2020.06.04.20122457 — Posted: 2020-06-05
SARS-CoV-2 proteases cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species and the search for reservoir hosts.
Moustaqil, M., Ollivier, E., Chiu, H.-P., Rudolffi-Soto, P., Van Tol, S., Stevens, C., Bhumkar, A., Hunter, D. J. B., Freiberg, A. N., Jacques, D., Lee, B., Sierecki, E., Gambin, Y.
10.1101/2020.06.05.135699 — Posted: 2020-06-05 Discussion: Offsite
SARS-CoV-2 infection leads to acute infection with dynamic cellular and inflammatory flux in the lung that varies across nonhuman primate species
Singh, D. K., Ganatra, S. R., Singh, B., Cole, J., Alfson, K. J., Clemmons, E., Gazi, M., Gonzalez, O., Escabedo, R., Lee, T.-H., Chatterjee, A., Goez-Gazi, Y., Sharan, R., Thippeshappa, R., Gough, M., Alvarez, C., Blakely, A., Ferdin, J., Bartley, C., Staples, H., Parodi, L., Callery, J., Mannino, A., Klaffke, B., Escareno, P., Platt, R. N., Hodara, V., Scordo, J., Oyejide, A., Ajithdoss, D. K., Copin, R., Baum, A., Kyratsous, C., Alvarez, X., Rosa, B., Ahmed, M., Goodroe, A., Dutton, J., Hall-Ursone, S., Frost, P., Voges, A. K., Ross, C. N., Sayers, K., Chen, C., Hallam, C., Khader, S. A., Mitreva, M., Anderson, T., Martinez-Sobrido, L., Patterson, J., Turner, J., Torrelles, J. B., Dick, E. J., Brasky, K., Schlesinger, L. S., Giavedoni, L., Kaushal, D., Carrion, R.
10.1101/2020.06.05.136481 — Posted: 2020-06-05 Discussion: Onsite | Offsite
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
Bertoglio, F., Meier, D., Langreder, N., Steinke, S., Rand, U., Simonelli, L., Heine, P. A., Ballmann, R., Schneider, K.-T., Roth, K. D. R., Ruschig, M., Riese, P., Eschke, K., Kim, Y., Schaeckermann, D., Pedotti, M., Kuhn, P., Zock-Emmenthal, S., Woehrle, J., Becker, M., Grashoff, M., Wenzel, E. V., Russo, G., Kroeger, A., Brunotte, L., Ludwig, S., Fuehner, V., Kraemer, S. D., Duebel, S., Varani, L., Roth, G., Cicin-Sain, L., Schubert, M., Hust, M.
10.1101/2020.06.05.135921 — Posted: 2020-06-05 Discussion: Onsite | Offsite
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.
Lephart, P. R., Bachman, M. A., LeBar, W., McClellan, S. W., Barron, K., Schroeder, L., Newton, D. W.
10.1101/2020.06.04.135616 — Posted: 2020-06-05
Design of a Novel Multiplex Real Time RT-PCR Assay for SARS-CoV-2 Detection
Zhen, W., Berry, G. J.
10.1101/2020.06.04.135608 — Posted: 2020-06-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).